This study introduces a novel imaging system utilizing Cerenkov luminescence microscopy (CLM) to visualize the activity of radioactive tracers in 3D tumor spheroids. The system integrates an EMCCD camera, a microscope objective, and a precise sample positioning setup, enabling the high-resolution detection of Cerenkov light emission from radiotracers in a light-tight environment. The characteristics of the new CLM system have been tested on glioblastoma multiforme (GLM) spheroids, subjected or not to X-ray radiotherapy. The system effectively differentiated irradiated from non-irradiated spheroids by detecting distinct variations in signal intensity, which were further validated through comparison with autoradiography and quantitative activity measurements. This demonstrates the system's ability to provide highly sensitive imaging of radiolabeled biological samples. The method offers new possibilities for studying radiopharmaceutical distribution and metabolic processes at the cellular level, making it a valuable tool for advancing both diagnostic and therapeutic radiopharmaceutical development, as well as for evaluating treatment efficacy.
Alborghetti, L., Vurro, F., Belloli, S., Rainone, P., Valtorta, S., Milani Capialbi, M., et al. (2025). Cerenkov luminescence microscopy: A novel approach for high-resolution radiotracer imaging. ISCIENCE, 28(11) [10.1016/j.isci.2025.113840].
Cerenkov luminescence microscopy: A novel approach for high-resolution radiotracer imaging
Moresco R. M.;
2025
Abstract
This study introduces a novel imaging system utilizing Cerenkov luminescence microscopy (CLM) to visualize the activity of radioactive tracers in 3D tumor spheroids. The system integrates an EMCCD camera, a microscope objective, and a precise sample positioning setup, enabling the high-resolution detection of Cerenkov light emission from radiotracers in a light-tight environment. The characteristics of the new CLM system have been tested on glioblastoma multiforme (GLM) spheroids, subjected or not to X-ray radiotherapy. The system effectively differentiated irradiated from non-irradiated spheroids by detecting distinct variations in signal intensity, which were further validated through comparison with autoradiography and quantitative activity measurements. This demonstrates the system's ability to provide highly sensitive imaging of radiolabeled biological samples. The method offers new possibilities for studying radiopharmaceutical distribution and metabolic processes at the cellular level, making it a valuable tool for advancing both diagnostic and therapeutic radiopharmaceutical development, as well as for evaluating treatment efficacy.| File | Dimensione | Formato | |
|---|---|---|---|
|
Alborghetti et al-2025-iScience-VoR.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
2.67 MB
Formato
Adobe PDF
|
2.67 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


